These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2155476

  • 21. Involvement of leukotriene B4 in arthritis models.
    Tsuji F, Oki K, Fujisawa K, Okahara A, Horiuchi M, Mita S.
    Life Sci; 1999; 64(3):PL51-6. PubMed ID: 10027755
    [Abstract] [Full Text] [Related]

  • 22. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
    Wittenberg HR, Kleemeyer K, Peskar BM, Peskar BA.
    Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Increased serum leukotriene B4 level in the active stage of rheumatoid arthritis in children.
    Gürsel T, Firat S, Ercan ZS.
    Prostaglandins Leukot Essent Fatty Acids; 1997 Mar; 56(3):205-7. PubMed ID: 9089799
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Antirheumatic drugs and eicosanoid synthesis.
    Moilanen E, Alanko J, Seppälä E, Nissilä M, Isomäki H, Vapaatalo H.
    Scand J Rheumatol Suppl; 1987 Mar; 67():10-6. PubMed ID: 2838895
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro.
    Moilanen E, Alanko J, Seppälä E, Vapaatalo H.
    Agents Actions; 1988 Jul; 24(3-4):387-94. PubMed ID: 2845746
    [Abstract] [Full Text] [Related]

  • 32. Leukotriene B4 metabolism in human leukocytes: fact or artefact?
    McMillan RM, Foster SJ, Dieppe PA.
    Agents Actions; 1987 Aug; 21(3-4):355-7. PubMed ID: 2825483
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Identification of prostaglandin E2 and leukotriene B4 in the synovial fluid of painful, dysfunctional temporomandibular joints.
    Quinn JH, Bazan NG.
    J Oral Maxillofac Surg; 1990 Sep; 48(9):968-71. PubMed ID: 2168477
    [Abstract] [Full Text] [Related]

  • 35. Prognostic factors in arthrocentesis of the temporomandibular joint: Comparison of bradykinin, leukotriene B4, prostaglandin E2, and substance P level in synovial fluid between successful and unsuccessful cases.
    Kaneyama K, Segami N, Sato J, Fujimura K, Nagao T, Yoshimura H.
    J Oral Maxillofac Surg; 2007 Feb; 65(2):242-7. PubMed ID: 17236928
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.
    Engelhardt G, Bögel R, Schnitzler C, Utzmann R.
    Biochem Pharmacol; 1996 Jan 12; 51(1):29-38. PubMed ID: 8534265
    [Abstract] [Full Text] [Related]

  • 38. Quantification of leukotriene B4 in synovial fluid by gas chromatography/tandem mass spectrometry.
    Dawson M, McGee CM, Brooks PM, Vine JH, Watson TR.
    Biomed Environ Mass Spectrom; 1988 Sep 12; 17(3):205-11. PubMed ID: 2850829
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Levels of different metabolites of arachidonic acid in synovial fluid of patients with arthrosis or rheumatoid arthritis].
    Grignani G, Zucchella M, Belai Beyene N, Brocchieri A, Saporiti A, Chériè Ligniére EL.
    Minerva Med; 1996 Mar 12; 87(3):75-9. PubMed ID: 8668291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.